# Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion

> **NCT01059474** · PHASE1 · COMPLETED · sponsor: **Banner Health** · enrollment: 9 (actual)

## Conditions studied

- Toxicity

## Interventions

- **DRUG:** transdermal DMPS

## Key facts

- **NCT ID:** NCT01059474
- **Lead sponsor:** Banner Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2011-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059474, "Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01059474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*